Skip to main content

Table 3 Function and bother scores (mean ± standard deviation; median) in dependence on Charlson Comorbidity Index (CCI)

From: Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment

CCI <5 5 >5
urinary function* 94 ± 12; 100 93 ± 12; 100 89 ± 16; 94
continence function* 92 ± 17; 100 90 ± 18; 100 82 ± 25; 100
irritative/obstructive function 97 ± 12; 100 97 ± 9; 100 96 ± 13; 100
urinary bother* 85 ± 19; 93 84 ± 16; 89 77 ± 22; 82
continence bother* 93 ± 20; 100 93 ± 20; 100 86 ± 29; 100
irritative/obstructive bother* 84 ± 19; 90 83 ± 16; 85 76 ± 21; 80
bowel function 93 ± 9; 96 93 ± 8; 96 91 ± 10; 96
bowel bother 94 ± 13; 100 94 ± 11; 100 92 ± 15; 100
sexual function* 49 ± 22; 51 37 ± 24; 37 31 ± 24; 29
sexual bother 68 ± 31; 75 64 ± 34; 69 52 ± 36; 50
hormonal function 92 ± 14; 100 90 ± 13; 100 90 ± 13; 100
hormonal bother 92 ± 13; 100 90 ± 15; 96 90 ± 15; 96
  1. *significant difference <5/5 vs. >5 (p < 0.01)
  2. † significant difference <5 vs. >5 (p < 0.01) and 5 vs. >5 (p = 0.03)